Form 4 for VIR Vir Biotechnology, Inc.
Accepted 2026-05-28 19:25:00 ET · period of report 2026-05-27 · accession 0001628280-26-038964 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-05-28 19:25 | 2026-05-27 | VIR | MORE ROBERT J | Dir | A - Grant | $0.00 | +8,000 | 48.7K | +20% | $0 |
| D | 2026-05-28 19:25 | 2026-05-27 | VIR | MORE ROBERT J | Dir | A - Grant | $0.00 | +16.0K | 16.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-27 | A | A | 8,000 | $0.00 | 48,656 | D | — | — | (F1) Acquisition of restricted stock units (RSUs) pursuant to the Issuer's Equity Incentive Plan. (F2) The RSUs will vest in full on May 27, 2027. |
| 2 | Derivative | Stock Option (Right to Buy) | 2026-05-27 | A | A | 16,000 | $0.00 | 16,000 | D | $9.10 · 2027-05-27 to 2036-05-26 | 16,000 Common Stock | (F4) The shares subject to the stock option will vest and become exercisable in full on May 27, 2027. |